EU firms targeted in calls for new biomarkers and drug development tools
This article was originally published in RAJ Devices
Executive Summary
Personalised medicine, biomarkers and systems biology are among the collaborative projects aimed specifically at small and medium-sized companies in the latest call for proposals under the EU's funding programme, FP71-3.